SKINSYNC AI INC. (CIK 0002154967) filed Form D

SkinSync AI Inc. filed a Form D with the SEC on September 11, 2026, disclosing a private fundraise. The filing (accession 0002154967-26-000001) signals the company is raising capital, though the specific round size, investor names, and use of proceeds are not detailed in the available public record.

Form D filings are required disclosures for companies conducting Regulation D exempt offerings under federal securities law. They represent a formal notification of fundraising activity but typically contain limited commercial detail beyond basic deal structure. The filing places SkinSync AI in the category of early- to growth-stage private companies seeking outside investment.

Little public information is currently available about the company's founding date, product focus, prior funding history, or market position. The company name suggests a focus on dermatology and artificial intelligence—potentially leveraging machine learning for skin analysis, diagnosis, or treatment planning—but the sources provided do not confirm specific product offerings or target customers.

The Form D filing indicates the company has begun or is preparing a fundraising process. Investors and observers tracking emerging AI-powered healthcare startups may find this filing on the SEC's EDGAR database, which publicly archives all Form D submissions as part of regulatory transparency requirements.